Chris H Polman, Joep Killestein, and Huub Schellekens

Neutralizing antibodies to interferon-beta may persist after cessation of therapy: what impact could they have?
Mult Scler 2006 12: 245-246. [PDF] [References]  

Bodil Petersen, Klaus Bendtzen, Nils Koch-Henriksen, Mads Ravnborg, Christian Ross, and Per Soelberg Sorensen The Danish Multiple Sclerosis Group

Persistence of neutralizing antibodies after discontinuation of IFNß therapy in patients with relapsing-remitting multiple sclerosis
Mult Scler 2006 12: 247-252. [Abstract] [PDF] [References]  

Per Soelberg Sorensen, Nils Koch-Henriksen, Mads Ravnborg, Jette Lautrup Frederiksen, K ai Jensen, Anne Heltberg, Hanne Schaldemose, Sven Deth, O le Kristensen, Mogens Worm, Egon Stenager, Hans Jacob Hansen, Bjarne Sivertsen, and Jesper Torring Danish Multiple Sclerosis Study Group

Immunomodulatory treatment of multiple sclerosis in Denmark: a prospective nationwide survey
Mult Scler 2006 12: 253-264. [Abstract] [PDF] [References]  

C Rajda, K Bencsik, J Füvesi, E Seres, L Vécsei, and J Bergquist

The norepinephrine level is decreased in the lymphocytes of long-term interferon-beta-treated multiple sclerosis patients
Mult Scler 2006 12: 265-270. [Abstract] [PDF] [References]  

M H Gottesman and S Friedman-Urevich

Interferon beta-1b (Betaseron®/Betaferon®) is well tolerated at a dose of 500 mg: interferon dose escalation assessment of safety (IDEAS)
Mult Scler 2006 12: 271-280. [Abstract] [PDF] [References]  

E Portaccio, V Zipoli, G Siracusa, S Sorbi, and M P Amato

Response to interferon-beta therapy in relapsing-remitting multiple sclerosis: a comparison of different clinical criteria
Mult Scler 2006 12: 281-286. [Abstract] [PDF] [References]  

J M van Noort, R Verbeek, J F Meilof, C H Polman, and S Amor

Autoantibodies against alpha B-crystallin, a candidate autoantigen in multiple sclerosis, are part of a normal human immune repertoire
Mult Scler 2006 12: 287-293. [Abstract] [PDF] [References]  

E Fainardi, M Castellazzi, T Bellini, M C Manfrinato, E Baldi, I Casetta, E Paolino, E Granieri, and F Dallocchio

Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 (MMP-9) as markers of disease activity in patients with multiple sclerosis
Mult Scler 2006 12: 294-301. [Abstract] [PDF] [References]  

S Marconi, M Acler, L Lovato, L De Toni, E Tedeschi, E Anghileri, S Romito, C Cordioli, and B Bonetti

Anti-GD2-like IgM autoreactivity in multiple sclerosis patients
Mult Scler 2006 12: 302-308. [Abstract] [PDF] [References]  

C C Ford, K P Johnson, R P Lisak, H S Panitch, G Shifroni, and J S Wolinsky The Copaxone® Study Group

A prospective open-label study of glatiramer acetate: over a decade of continuous use in multiple sclerosis patients
Mult Scler 2006 12: 309-320. [Abstract] [PDF] [References]  

C Lebrun, H Alchaar, M Candito, V Bourg, and M Chatel

Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigue
Mult Scler 2006 12: 321-324. [Abstract] [PDF] [References]  

A Petzold, M J Eikelenboom, G Keir, C H Polman, B MJ Uitdehaag, E J Thompson, and G Giovannoni

The new Global Multiple Sclerosis Severity Score (MSSS) correlates with axonal but not glial biomarkers
Mult Scler 2006 12: 325-328. [Abstract] [PDF] [References]  

Henrik Brønnum-Hansen, Thomas Hansen, Nils Koch-Henriksen, and Egon Stenager

Fatal accidents among Danes with multiple sclerosis
Mult Scler 2006 12: 329-332. [Abstract] [PDF] [References]  

J S Sloka, W EM Pryse-Phillips, and M Stefanelli

The relation between menarche and the age of first symptoms in a multiple sclerosis cohort
Mult Scler 2006 12: 333-339. [Abstract] [PDF] [References]  

U Einarsson, K Gottberg, L von Koch, S Fredrikson, C Ytterberg, Y P Jin, M Andersson, and L Widén Holmqvist

Cognitive and motor function in people with multiple sclerosis in Stockholm County
Mult Scler 2006 12: 340-353. [Abstract] [PDF] [References]  

J Guimarães, M J Cardoso, and M J Sá

Tau protein seems not to be a useful routine clinical marker of axonal damage in multiple sclerosis
Mult Scler 2006 12: 354-356. [Abstract] [PDF] [References]  

S Sotgiu, G Arru, M Söderström, G Mameli, C Serra, and A Dolei

Multiple sclerosis-associated retrovirus and optic neuritis
Mult Scler 2006 12: 357-359. [Abstract] [PDF] [References]  

Smiljana Ristic, Luca Lovrecic, Nada Starcevic-Cizmarevic, Bojana Brajenovic-Milic, Sasa Sega Jazbec, Vesna Barac-Latas, Danilo Vejnovic, Juraj Sepcic, Miljenko Kapovic, and Borut Peterlin

No association of CCR5D32 gene mutation with multiple sclerosis in Croatian and Slovenian patients
Mult Scler 2006 12: 360-362. [Abstract] [PDF] [References]  

Norman Putzki, Sabine Knipp, T im Ramczykowski, Susanne Vago, Ulrich Germing, H. Chr. Diener, and Volker Limmroth

Secondary myelodysplastic syndrome following long-term treatment with azathioprine in patients with multiple sclerosis
Mult Scler 2006 12: 363-366. [Abstract] [PDF] [References]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.